drug · small molecule
LP-310
Phase 2updated 3mo agoby $LIPO LIPELLA PHARMACEUTICALS INC.🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 8- tagApproval16 co-mentions · 8 sources
- companyAstellas Pharma US Inc8 co-mentions · 2 sources
- tagSmall Molecule8 co-mentions · 8 sources
- companyAstellas Pharma Inc8 co-mentions · 2 sources
- drug386574 co-mentions · 2 sources
- drugTACROLIMUS4 co-mentions · 2 sources
- tagRecall4 co-mentions · 2 sources
- companyBiocon Pharma Ltd3 co-mentions · 3 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 9 approved and 18 investigational indications.
targets
Peptidyl-prolyl cis-trans isomerase FKBP1A
all catalysts(0)
nothing on the calendar yet
Trials studying LP-310
- phase3A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
- phase2Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
- phase3A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy
- phase3Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
- phase2CC-101 (f/k/a NR1) Neural Stem Cell Transplantation for Adults With Chronic Ischemic Stroke
- phase4Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants
- phase3A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
- phase3A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
News(4)
- With $263M, LifeMine unearths a new drug for organ transplantsLed by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplanted organs.biopharma_dive · 9d ago
- LifeMine raises $263M in mission to improve organ transplant aftercarePatients who receive an organ transplant must take difficult immuno-suppressive medicines for the rest of their lives. LifeMine Therapeutics wants to offer a safer alternative.biospace · 9d ago
- ‘Greg, you’ve got to bring back this platform’: How LifeMine won over Gates and Bezos for $188M series EA little over a year ago, LifeMine Therapeutics laid off staff and put its fungus-based platform on ice to focus its dwindling resources on its lead asset. Now, the Massachusetts biotech is shaking…fiercebiotech · 9d ago
- Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceAfter the trailblazing approval of Sanofi’s Tzield for stage 3 type 1 diabetes, several companies, including SAB Biotherapeutics and Eledon Pharmaceuticals, are vying for a spot in the landscape wi…biospace · 26d ago
Data sources
last refreshed 32m ago
Found something off?
comments(0)
5-min edit window · permanent after that